Delivery Order SPE2DB20D3505-SPE2DB25FT8V0
Award Date 1/27/25
Potential Completion Date 1/28/25
Potential Value $2.6K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award is from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the delivery of 4,555,355,594 units of PROLENSA 0.07% eye drops in 3 milliliter vials. The firm-fixed-price delivery order, valued at $16,328.27, has a period of performance through November 9, 2021. This award is not designated as a set-aside contract. The contract is part of a larger Indefinite Delivery Contract (IDC)...
- This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,564.48 Firm Fixed Price Delivery Order contract is for the supply of PROLENSA 0.07% eye drops (3mL). The contract has a completion date of November 7, 2024. Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
- This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The award, valued at $2,670.64, is for the delivery of PROLENSA 0.07% eye drops in 3mL containers. This is a Firm Fixed Price Delivery Order contract with a period of performance through November 4, 2024. The award is not associated with a set-aside program and appears to be an open competition. Amerisourcebergen holds a significant Indefinite Delivery...
- This federal contract award, valued at $7,455.04, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4560410185 PROLENSA 0.07% eye drops, a specialty pharmaceutical product, with a period of performance through March 29, 2023. This delivery order is under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, which...
- This federal contract award is for the delivery of PROLENSA 0.07% eye drops (3ml) to the Defense Logistics Agency (DLA) Troop Support Medical, a division of the Department of Defense (DoD). The contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc., on September 26, 2023, with a total ceiling value of $19,398.20 and a completion date of September 27, 2023. The contract is a delivery order with a firm fixed-price pricing type. This contract is not...
- This is a firm fixed-price delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $2,975.54 contract is for the supply of PROLENSA 0.07% eye drops. The contract has a period of performance through May 6, 2025 and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which provides a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4,560,258,236 units of PROLENSA 0.07% eye drops. The Firm Fixed Price delivery order, valued at $4,319.98, has a period of performance through March 15, 2023. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of PROLENSA 0.07% eye drops (3 mL). The $1,777.03 firm fixed-price delivery order does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that serves as a primary vehicle for providing a comprehensive range of...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distribution company. The $2,148.47 firm fixed-price delivery order is for the supply of PROLENSA 0.07% eye drops. The contract has an ultimate completion date of January 4, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle...
- This is a delivery order under the Defense Logistics Agency (DLA) Troop Support Medical Indefinite Delivery Contract (IDC), valued at up to $999,999,999 through December 2025. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor, which has been awarded a contract to supply a variety of prescription medications, over-the-counter drugs, and medical supplies to support military treatment programs and facilities worldwide. The specific item being delivered under...